Subhabrata Moitra
Prof Subhabrata Moitra, PhD, FRSPH is an expert in Pulmonology at Ahmedabad University (India). As of November 2026, ScienceLeadR ranks Subhabrata Moitra in the top 1% of experts in India for Lung Diseases, Obstructive. Subhabrata Moitra has authored 89 publications, the most recent in 2026, and is an investigator in 1 clinical trial, 1 of them ongoing. SLR score: 348 (community average: 125). How the SLR is computed.
LeadR Profile
Pulmonology
Subspecialties: Immunology - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2013 - 2026Ahmedabad University - Assistant Professor
2024 - 2026
Number : 89
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Benralizumab Inhibits Upper Airway Expression of Thymic Stromal Lymphopoietin in Severe Asthma. PMID 42963590 — hypersensitivity, asthma | Clin Exp Allergy | 2026 | 0 |
| Toxic skies of war. PMID 42208953 | Lancet Respir Med Top journal | 2026 | 0 |
| Association Between Asthma and Chronic Bone Diseases: A Cross-Sectional Analysis From the Longitudinal Ageing Study in India (LASI) Data. PMID 41956479 — cross-sectional studies, hypersensitivity, bone diseases, asthma | Clin Exp Allergy | 2026 | 0 |
| Tezepelumab Reduces Alarmin Cytokine Levels in Upper Airway Epithelial Cells in Patients With Severe Asthma. PMID 41896176 — cytokines, cells, epithelial cells, hypersensitivity, alarmins, asthma | Clin Exp Allergy | 2026 | 0 |
| Asthma and higher social isolation among middle-aged adults: A structural equation analysis of nationwide data in India. PMID 41687870 — hypersensitivity, social isolation, aged, asthma | J Allergy Clin Immunol Pract | 2026 | 1 |
Clinical Studies 1
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA) NCT06705764 — emergencies, therapeutics, asthma, steroids, emergency service, hospital | Phase 4 | Recruiting | 2026 |
LeadR Networks
Main global connection map